» Articles » PMID: 19243518

Effect of Body Mass Index on the Outcome of Infections: a Systematic Review

Overview
Journal Obes Rev
Specialty Endocrinology
Date 2009 Feb 27
PMID 19243518
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

It has not been adequately evaluated whether the outcome of infections differs by body-weight category. We performed a systematic review of relevant studies. Eleven studies (one retrospective and 10 prospective cohort studies) were included in this review, involving a total of 3159 hospitalized patients or nursing home residents. Most studies (6/11) referred to lower respiratory tract infections. Seven studies showed an association of patient outcome (mortality in 6/7 studies) with body-weight category. This was shown in multivariate analysis in 4/5 studies that reported relevant data. Obese or morbidly obese patients with infections had worse outcome compared with the rest of the patients or with normal-weight patients, in 4/7 studies that reported relevant data; findings were not significant in the remaining three studies. Patients in the lowest body mass index (BMI) group had worse outcome compared with all other groups combined, in 3/5 studies that reported relevant data; findings were not significant in the remaining two studies. Low BMI was associated with worse outcome in patients with lower respiratory tract infections in 3/4 relevant studies. Although not consistently reported, an association of both ends of the BMI distribution with worse outcome of infections is plausible and merits further investigation.

Citing Articles

Comparison of surgical wound infection and dehiscence following the use of two methods of nylon sutures and skin staples in staples in diabetic mellitus patients undergoing total knee arthroplasty surgery: a randomized clinical trial study.

Rahbari H, Ahmadi M, Doreh M, Mahmoudi S, Ghaemmaghami P, Fereidouni A BMC Musculoskelet Disord. 2025; 26(1):70.

PMID: 39828687 PMC: 11744891. DOI: 10.1186/s12891-024-08263-7.


Efficacy of Ciprofloxacin in Treating Gram-Negative Infections: Does Obesity Matter?.

Alotaibi S, Damfu N, Alnefaie A, Alqurashi A, Althagafi S, Alotaibi A Pharmacy (Basel). 2024; 12(5).

PMID: 39452803 PMC: 11511332. DOI: 10.3390/pharmacy12050147.


Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients.

Caubergs V, Van den Broucke E, Mertens B, Gijsen M, Peetermans W, Van Wijngaerden E Infection. 2024; 52(6):2297-2314.

PMID: 38967768 DOI: 10.1007/s15010-024-02279-w.


The chemerin-CMKLR1 axis in keratinocytes impairs innate host defense against cutaneous Staphylococcus aureus infection.

Chen Y, Song Y, Wang Z, Lai Y, Yin W, Cai Q Cell Mol Immunol. 2024; 21(6):533-545.

PMID: 38532043 PMC: 11143357. DOI: 10.1038/s41423-024-01152-y.


Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study.

Sano H, Fukushima K, Yano M, Osone S, Kato Y, Hasegawa D Int J Hematol. 2024; 119(6):745-754.

PMID: 38460081 DOI: 10.1007/s12185-024-03745-9.